Medicis (MRX +2.5%) gains on positive comments out of Deutsche earlier this morning. Deutsche...

|By:, SA News Editor

Medicis (MRX +2.5%) gains on positive comments out of Deutsche earlier this morning. Deutsche says that after meeting with management, it believes its product pipeline is strong, an the launch of Zyclara shows a lot of promise. The firm ups its price target to $44 from $41 and reiterates its a Buy rating on the stock.